Search Results 1531-1540 of 18443 for Immunode

1. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on anti-retroviral treatment and have detectable viral load and CD4+ ...

2. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

   - Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on anti-retroviral treatment and have detectable viral load and ...

3. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

   - Participants with known human immunodeficiency virus (HIV)-infection must be receiving anti-retroviral therapy and have an undetectable viral load test on ...

4. A Study to Evaluate the Effectiveness and Safety of Apraglutide in Adults with Short Bowel Syndrome and Intestinal Failure - Mayo Clinic

   Positive results for human immunodeficiency virus (HIV), hepatitis A, B and/or C tests at the Screening Visit 4. Elevated liver enzymes during the screening ...

5. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   Patients with a known history of human immunodeficiency virus (HIV) seropositivity must: 1) have undetectable viral load using standard HIV assays in ...

6. Focus areas - Division of Infectious Diseases - Mayo Clinic Research

   Hematology/oncology. Faculty. Paschalis Vergidis, M.D., M.S.; John W. Wilson, M.D.. HIV. Laboratories. Human Immunodeficiency Virus: ...

7. A Study to Assess Dendritic Cell Immunotherapy Plus Standard-of-Care to Treat Advanced Renal Cell Carcinoma - Mayo Clinic

   signs/symptoms of autoimmune disease are not exclusionary. 9. Clinically significant infections, including human immunodeficiency virus (HIV), syphilis, and ...

8. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

   - Known history of human immunodeficiency virus (HIV) seropositivity - Administration of a live, attenuated vaccine within 4 weeks before first study

9. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR) - Mayo Clinic

   Diagnosis of the following PAH Group 1 subtypes: human immunodeficiency virus (HIV)-associated PAH and PAH associated with portal hypertension. Exclusions ...

10. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

    ... immunodeficiency virus (HIV) positivity are allowed if CD4 count > 500 cells/uL. No known active or uncontrolled infections requiring ongoing antifungals or ...